• ChemicalBook
    Chinese english Germany Japanese Korea

    Lysergid Produkt Beschreibung

    LSD Struktur
    50-37-3
    CAS-Nr.
    50-37-3
    Bezeichnung:
    Lysergid
    Englisch Name:
    LSD
    Synonyma:
    LSA;LSD;Cubes;D-LSD;Ergine;LSD 25;lsd-25;C07542;Delysid;DNAS1L3
    CBNumber:
    CB7418655
    Summenformel:
    C20H25N3O
    Molgewicht:
    323.44
    MOL-Datei:
    50-37-3.mol

    Lysergid Eigenschaften

    Schmelzpunkt:
    91-93?C
    alpha 
    D20 +17° (c = 0.5 in pyridine)
    Siedepunkt:
    461.9°C (rough estimate)
    Dichte
    1.1021 (rough estimate)
    Brechungsindex
    1.6200 (estimate)
    Flammpunkt:
    2℃
    storage temp. 
    −20°C
    pka
    pKa 7.5 (Uncertain)
    Stabilit?t:
    Stable. Incompatible with strong oxidizing agents.
    EPA chemische Informationen
    Lysergide (50-37-3)
    Sicherheit
    • Risiko- und Sicherheitserkl?rung
    • Gefahreninformationscode (GHS)
    Kennzeichnung gef?hrlicher T+,T,F,Xn
    R-S?tze: 26/27/28-40-36/38-23/25-36-20/21/22-11
    S-S?tze: 22-28-36-45-33-24-16-7-36/37-26
    RIDADR  UN 2811 6.1/PG 1
    WGK Germany  3
    RTECS-Nr. KE4100000
    Giftige Stoffe Daten 50-37-3(Hazardous Substances Data)
    Toxizit?t LD50 in mice, rats, rabbits (mg/kg): 46, 16.5, 0.3 i.v.
    Bildanzeige (GHS)
    Alarmwort Achtung
    Gefahrenhinweise
    Code Gefahrenhinweise Gefahrenklasse Abteilung Alarmwort Symbol P-Code
    H225 Flüssigkeit und Dampf leicht entzündbar. Entzündbare Flüssigkeiten Kategorie 2 Achtung P210,P233, P240, P241, P242, P243,P280, P303+ P361+P353, P370+P378,P403+P235, P501
    H319 Verursacht schwere Augenreizung. Schwere Augenreizung Kategorie 2 Warnung P264, P280, P305+P351+P338,P337+P313P
    H331 Giftig bei Einatmen. Akute Toxizit?t inhalativ Kategorie 3 Achtung P261, P271, P304+P340, P311, P321,P403+P233, P405, P501
    Sicherheit
    P210 Von Hitze, hei?en Oberfl?chen, Funken, offenen Flammen und anderen Zündquellenarten fernhalten. Nicht rauchen.
    P261 Einatmen von Staub vermeiden.
    P337+P313 Bei anhaltender Augenreizung: ?rztlichen Rat einholen/?rztliche Hilfe hinzuziehen.
    P403+P233 An einem gut belüfteten Ort aufbewahren. Beh?lter dicht verschlossen halten.
    P403+P235 An einem gut belüfteten Ort aufbewahren. Kühl halten.

    Lysergid Chemische Eigenschaften,Einsatz,Produktion Methoden

    R-S?tze Betriebsanweisung:

    R26/27/28:Sehr giftig beim Einatmen, Verschlucken und Berührung mit der Haut.
    R40:Verdacht auf krebserzeugende Wirkung.
    R36/38:Reizt die Augen und die Haut.
    R23/25:Giftig beim Einatmen und Verschlucken.

    S-S?tze Betriebsanweisung:

    S22:Staub nicht einatmen.
    S28:Bei Berührung mit der Haut sofort abwaschen mit viel . . . (vom Hersteller anzugeben).
    S36:DE: Bei der Arbeit geeignete Schutzkleidung tragen.
    S45:Bei Unfall oder Unwohlsein sofort Arzt zuziehen (wenn m?glich, dieses Etikett vorzeigen).
    S33:Ma?nahmen gegen elektrostatische Aufladungen treffen.
    S24:Berührung mit der Haut vermeiden.
    S16:Von Zündquellen fernhalten - Nicht rauchen.
    S7:Beh?lter dicht geschlossen halten.

    Beschreibung

    Lysergic acid diethylamide (LSD) is synthetically derived from the fungus, Claviceps purpuria. Several isomers of this compound exist, although only the D-isomer is considered active. LSD was first synthesized by Albert Hofmann in 1938 in a search for an analeptic drug. After finding its psychogenic activity, it was marketed by Sandoz laboratories under the name Delysid?. It was also reportedly used by the Central Intelligence Agency as a tool for interrogation. Due to its potential for ‘bad trips,’ ‘flashbacks,’ and potential risk for brain injury, LSD was banned federally in 1966 and is currently only used illicitly. LSD is chemically similar to other naturally occurring lysergamides found in multiple species of morning glory.

    Chemische Eigenschaften

    crystalline solid

    Verwenden

    Labelled Lysergide (L488010)

    Verwenden

    Potent hallucinogen; non-selective serotonin receptor agonist. Has been used experimentally as adjunct in study and treatment of mental disorders. Controlled substance.

    Verwenden

    LSD is obtained by partial synthesis fromD-lysergic acid. It is also produced bymicrobial reaction of Claviceps paspali overthe hydroxylethylamide. It is a well-knownhallucinogen and a drug of abuse, listed asa controlled substance in the U.S. Code ofFederal Regulations (Title 21, Part 1308.11,1987). It is used as an antagonist to serotoninand in the study and treatment of mentaldisorders.

    Definition

    ChEBI: An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

    Allgemeine Beschreibung

    Prismatic crystals (from benzene). Tasteless and odorless. A hallucinogen.

    Reaktivit?t anzeigen

    An amide. Organic amides/imides react with azo and diazo compounds to generate toxic gases. Flammable gases are formed by the reaction of organic amides/imides with strong reducing agents. Amides are very weak bases (weaker than water). Imides are less basic yet and in fact react with strong bases to form salts. That is, they can react as acids. Mixing amides with dehydrating agents such as P2O5 or SOCl2 generates the corresponding nitrile. The combustion of these compounds generates mixed oxides of nitrogen (NOx).

    Health Hazard

    LSD is a strong psychedelic agent. Theeffects in human are excitement, euphoria,hallucinations, and distorted perceptions.It alters the thinking process, producingillusions and loss of contact with reality.In humans, a dose (intramuscular)of 0.7–0.9 mg/kg or an oral dose of2.5–3.0 mg/kg may produce the effectsabove. Other symptoms may include nausea,vomiting, dilation of pupils, restlessness, andperipheral vascoconstriction. However, thereis no reported case of overdose death. In rabbits,somnolence, ataxia, and an increase inbody temperature were the symptoms notedat the LD50 (intravenous) doses at 0.3 mg/kg.
    LD50 value, intravenous (mice): 46 mg/kg
    LD50 value, subcutaneous (guinea pigs):16 mg/kg.

    Brandgefahr

    Flash point data for LSD are not available; however LSD is probably combustible.

    Sicherheitsprofil

    Poison by ingestion, subcutaneous, intraperitoneal, and intravenous routes. Mutation data reported. Human systemic effects by ingestion and intramuscular routes: euphoria, hallucinations, distorted perceptions, excitement, anorexia, nausea and vomiting. An experimental teratogen. Other experimental reproductive effects. Mutation data reported. A much-abused hallucinogen. A federally regulated substance. When heated to decomposition it emits toxic fumes of NOx

    Environmental Fate

    LSD may exist in the air or soil. In the air, LSD may be susceptible to photochemical reactions with subsequently induced radical analogs. Photolysis and oxidative degradation may occur with an airborne half-life of 18 min. LSD’s pKa of 7.8 will have a meaningful percentage of the drug in the cationic form allowing it to interact with soil.

    Toxicity evaluation

    LSD’s mechanism of action is not completely understood. LSD’s hallucinogenic effects are secondary to its ability to increase central serotonin activity. LSD also stimulates both D1 and D2 dopamine receptors.

    Lysergid Upstream-Materialien And Downstream Produkte

    Upstream-Materialien

    Downstream Produkte


    Lysergid Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.

    Global( 0)Lieferanten
    Firmenname Telefon Fax E-Mail Land Produktkatalog Edge Rate

    50-37-3(Lysergid)Verwandte Suche:


    • 10-didehydro-n,n-diethyl-6-methyl-(8beta)-ergoline-8-carboxamid
    • 9,10-didehydro-n,n-diethyl-6-methyl-ergoline-8-beta-carboxamid
    • 9,10-didehydro-n,n-diethyl-6-methyl-ergoline-8beta-carboxamid
    • 9,10-Didehydro-N,N-diethyl-6-methyl-ergoline-8-beta-carboxamide
    • Cubes
    • Delysid
    • Dextrolysergic Acid diethylamide
    • Diethylamid kyseliny lysergove
    • diethylamidkyselinylysergove
    • D-LSD-25
    • d-Lysergic acid dethylamide
    • D-Lysergic acid diethylamide
    • D-Lysergic acid N,N-diethylamide
    • d-lysergicaciddiethylamide
    • Ergine
    • Ergoline-8beta-carboxamide, 9,10-didehydro-N,N-diethyl-6-methyl-
    • Ergoline-8-carboxamide, 9,10-didehydro-N,N-diethyl-6-methyl-, (8beta)-
    • Heavenly blue
    • heavenlyblue
    • Indolo[4,3-fg]quinoline, ergoline-8-carboxamide deriv.
    • LSA
    • LSD (Alkaloid)
    • LSD 25
    • lsd[alkaloid]
    • lsd-25
    • Lysergamid
    • Lysergamide
    • Lysergamide, N,N-diethyl-
    • Lysergaure diethylamid
    • lysergaurediethylamid
    • Lysergic acid amide
    • Lysergic acid diethylamide-25
    • lysergicaciddiethylamide-25
    • lysergsaeurediaethylamid
    • Lysergsauerediaethylamid
    • Lysergsaure diethylamid
    • lysergsaurediethylamid
    • N,N-Diethyl-(+)-Lysergamide
    • N,N-Diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide
    • N,N-Diethyl-D-lysergamide
    • n,n-diethyl-lysergamid
    • N,N-Diethyllysergamide
    • Pearly gates
    • pearlygates
    • Royal blue
    • royalblue
    • Wedding bells
    • D-LYSERGIC ACID DIETHYLAMIDE TARTRATE
    • LYSERGIC ACID DIETHYLAMIDE*--DEA SCHEDUL E I ITEM
    • LSD
    • LYSERGIC ACID DIETHYLAMIDE
    • LYSERGIDE
    • D-LSD
    • LYSERGIC ACID DIETHYLAMIDE, 25 UG/ML*IN METHANOL
    • D-LYSERGIC ACID DIETHYLAMIDE TARTRATE PO TENT HALLUCINOGEN,
    • D-LYSERGIC ACID DIETHYLAMIDE TARTRATE (D ELYSID)
    • LSD, Lysergide
    • Lysergic Acid Diethylamide TartrateCI
    Copyright 2019 ? ChemicalBook. All rights reserved